Loss of Consciousness in a Child Following Accidental Ingestion of Brimonidine Ointment: A Case Report Authors: Ramin Zareh Mahmoudabadi, Maryam Vafapour, Majid Karrobi, Zahra Noori Etemad, Mohammad Mohammadi, Seyed Reza Gholizadeh, Aynaz Mohammadi Published: 2026 ABSTRACT ABSTRACTBrimonidine ingestion in young children can cause rapid, severe central nervous system (CNS) depression, including miosis and hypotonia. Clinicians should maintain a high index of suspicion in toddlers presenting with unexplained drowsiness following exposure. Prompt airway management and supportive care are critical, as naloxone may improve symptoms in these cases. Introduction Brimonidine, a selective alpha‐2 adrenergic receptor agonist, is widely used as a topical medication for rosacea and as an ophthalmic agent to lower intraocular pressure in glaucoma patients [1]. While its effects in adults are well established, pediatric exposure—especially by the ingestion—can result in severe toxicity due to children's underdeveloped metabolic systems and increased drug sensitivity [2]. Toxicity often manifests as central nervous system (CNS) depression, respiratory failure, and cardiovascular instability [3]. This report describes a rare case of brimonidine toxicity in a child, highlighting the challenges in diagnosis and management, and emphasizing the need for preventive strategies. Case Presentation Case History/Examination A 14‐month‐old girl, the second child of consanguineous parents, was brought to the emergency department with altered mental status after accidentally ingesting brimonidine ointment. The ointment had been left within her reach during play. The mother reported that within two hours of ingestion, the child became drowsy and ataxic, and exhibited persistent irritability. On examination, the patient was drowsy but hemodynamically stable. Her vital signs were within the normal range for her age: blood pressure 100/65 mmHg, respiratory rate 27/min, heart rate 110/min, and oxygen saturation 99% on room air. The pupils were constricted (miotic) but reacted to light. Lungs were clear on auscultation, with no distress. Heart sounds (S1, S2) were regular with no murmurs, and capillary refill was under 2 s. The abdomen was soft and non‐distended, without enlargement of the liver or spleen. The skin showed no signs of cyanosis, jaundice, or bruising. The genitourinary exam was normal except for mild redness around the labia. Differential Diagnoses Differential diagnoses included ingestion of toxic substances (e.g., opioids, clonidine, or sedative‐hypnotics), metabolic disturbances (e.g., hypoglycemia, electrolyte imbalances), and acute neurological events (e.g., status epilepticus, meningitis). Investigations Laboratory tests showed mild anemia (hemoglobin 10.2 g/dL) and mild thrombocytopenia (platelets 97,000/mm3); both normalized at follow‐up testing. The white blood cell count was normal, with 68% neutrophils. The kidney and liver function tests were normal, and electrolytes were stable. Coagulation studies (PT and PTT) were normal. An arterial blood gas analysis showed compensated respiratory alkalosis (pH 7.46, pCO2 31 mmHg, HCO3 32.8 mEq/L). The troponin level was slightly elevated at 1.5 ng/mL, so the patient was monitored for cardiac issues. Treatment These findings suggested CNS depression from drug toxicity. Naloxone (0.1 mg/kg) was given intravenously, leading to improved consciousness within 10 min. However, the child's pupils remained constricted. She was admitted to the pediatric intensive care unit (PICU) for 24‐h monitoring. Supportive care included intravenous fluids and continuous observation. A naloxone infusion was maintained at an appropriate rate for 24 h and then gradually stopped. After the infusion ended, the patient was observed for another 24 h and then discharged on day 3 of hospitalization in stable condition with no neurological deficits. Discussion Brimonidine is a selective alpha‐2 agonist used to treat glaucoma by reducing intraocular pressure [3, 4]. In cases of overdose, it can cause effects similar to clonidine poisoning. Common signs of brimonidine toxicity include miosis (pinpoint pupils), low body temperature, dizziness, drowsiness or coma, apnea (temporary breathing pause), blood pressure changes, bradycardia (slow heart rate), and respiratory depression [3, 5]. Because brimonidine is very fat‐soluble, it crosses into the blood–brain barrier easily [6]. Young children are especially vulnerable to these effects. They have thinner skin and a higher surface area‐to‐weight ratio, which can increase systemic absorption of topical drugs. Their blood–brain barrier is not fully developed, and they have a smaller blood volume, thus, a specific dose can lead to more pronounced effects [4, 7, 8]. In reported poisonings, almost half of the cases involved children under age five [9]. This highlights the risk, as even small ingestions can produce severe CNS depression in infants and toddlers. Brimonidine is metabolized in the liver, and its metabolites are excreted by the kidneys [2]. It has a half‐life of about three hours, but symptoms can last longer in children due to slower metabolism [4]. Supportive care is the main treatment. Naloxone (an opioid antagonist) has been effective in some cases. One analysis found that naloxone was used in approximately 10% of pediatric cases and was more common in moderate or severe poisonings [9]. In our patient, naloxone led to clear improvement in her clinical status. Management also includes monitoring vital signs, giving IV fluids, and providing respiratory support if needed [9]. Overall, this case demonstrates that naloxone can reverse brimonidine's effects, but prevention through safe storage of medications is crucial to avoid such incidents [4]. Limitations Laboratory confirmation of brimonidine levels was not performed because specialized assays such as high‐performance liquid chromatography–tandem mass spectrometry (HPLC‐MS/MS) [4] were not accessible at our facility. Therefore, the diagnosis was established based on the patient's clinical presentation and medical history. Conclusion Brimonidine ingestion in children can cause serious systemic toxicity. This case underscores the clinical significance of recognizing the symptoms and initiating prompt treatment. Naloxone should be considered a potential intervention to reverse the effects of brimonidine overdose. However, the most effective strategy remains prevention: medications must be stored in secure, child‐proof locations, and caregivers should be educated about safe storage. Public awareness and safety measures such as child‐resistant packaging are crucial to mitigating such accidents. Author Contributions Ramin Zareh Mahmoudabadi: writing – review and editing. Maryam Vafapour: writing – review and editing. Majid Karrobi: writing – review and editing. Zahra Noori Etemad: resources, writing – original draft. Mohammad Mohammadi: writing – original draft, writing – review and editing. Seyed Reza Gholizadeh: resources, writing – original draft. Aynaz Mohammadi: project administration, supervision, writing – review and editing. Funding The authors have nothing to report. Consent Written informed consent was obtained from the patient's parents for publication of this case report. Conflicts of Interest The authors declare no conflicts of interest.